1,956
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Importance of long-term monitoring of patients with breast reconstructions: a case of 10-year cancer recurrence

, , &
Pages 1-6 | Received 23 Apr 2020, Accepted 22 Nov 2021, Published online: 13 Dec 2021

References

  • Bucchi L, Belli P, Benelli E, et al. Recommendations for breast imaging follow-up of women with a previous history of breast cancer: position paper from the Italian group for mammography screening (GISMa) and the italian college of breast radiologists (ICBR) by SIRM. Radiol Med. 2016;121(12):891–896.
  • Freyvogel M, Padia S, Larson K, et al. Screening mammography following autologous breast reconstruction: an unnecessary effort. Ann Surg Oncol. 2014;21(10):3256–3260.
  • Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–1232.
  • Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996;14(10):2738–2746.
  • Petit JY, Gentilini O, Rotmensz N, et al. Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution. Breast Cancer Res Treat. 2008;112(3):545–549.
  • Colleoni M, Sun Z, Price KN, et al. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V. J Clin Oncol. 2016;34(9):927–935.
  • Arvold ND, Taghian AG, Niemierko A, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011;29(29):3885–3891.
  • van der Leij F, Elkhuizen PH, Bartelink H, et al. Predictive factors for local recurrence in breast cancer. Semin Radiat Oncol. 2012;22(2):100–107.
  • Childs SK, Chen YH, Duggan MM, et al. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013;85(4):948–952.
  • Kim JH, Tavassoli F, Haffty BG. Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature. Cancer J. 2006;12(2):92–101.
  • Mamtani A, Nakhlis F, Downs-Canner S, et al. Impact of age on locoregional and distant recurrence after mastectomy for ductal carcinoma in situ with or without microinvasion. Ann Surg Oncol. 2019;26(13):4264–4271.
  • Takeuchi H, Muto Y, Tashiro H. Clinicopathological characteristics of recurrence more than 10 years after surgery in patients with breast carcinoma. Anticancer Res. 2009;29(8):3445–3448.
  • Hedegard W, Niell B, Specht M, et al. Breast reconstruction with a deep inferior epigastric perforator flap: imaging appearances of the normal flap and common complications. AJR Am J RoentGenol. 2013;200(1):W75–W84.
  • Pinel-Giroux FM, El Khoury MM, Trop I, et al. Breast reconstruction: review of surgical methods and spectrum of imaging findings. Radiographics. 2013;33(2):435–453.
  • Huiskes JVM, Keemers-Gels ME, Fabré J, et al. DIEAP flap breast reconstruction followed by local recurrence of breast cancer. Case Rep Oncol. 2018;11(2):493–498.
  • Rabey NG, Lie KH, Kumiponjera D, et al. Salvage of failed prosthetic breast reconstructions by autologous conversion with free tissue transfers. Eplasty. 2013;13:e32.
  • National Institute for Health and Care Excellence (NICE). 2017. NICE clinical guideline 164 [CG164]: familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. National Institute for Health and Care Excellence (NICE), Manchester. https://www.nice.org.uk/guidance/cg164.
  • The Royal College of Radiologists. Guidance on screening and symptomatic breast imaging. Fourth edition. London: The Royal College of Radiologists; 2019.
  • :Mainiero MB, Moy L, Baron P, Expert Panel on Breast Imaging, et al. ACR appropriateness criteria® breast cancer screening. J Am Coll Radiol. 2017;14(11S):S383–S390.
  • Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of clinical oncology breast cancer survivorship care guideline. CA Cancer J Clin. 2016;66(1):43–73.
  • Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v8–v30.
  • Gradishar WJ, Anderson BO, Abraham J, et al. Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(4):452–478.
  • Swinnen J, Keupers M, Soens J, et al. Breast imaging surveillance after curative treatment for primary non-metastasised breast cancer in non-high-risk women: a systematic review. Insights Imag. 2018;9(6):961–970.
  • Reddy S, Colakoglu S, Curtis MS, et al. Breast cancer recurrence following postmastectomy reconstruction compared to mastectomy with no reconstruction. Ann Plast Surg. 2011;66(5):466–471.
  • Patterson SG, Teller P, Iyengar R, et al. Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction. Ann Surg Oncol. 2012;19(8):2679–2684.
  • Lee JM, Georgian-Smith D, Gazelle GS, et al. Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions. Radiology. 2008;248(2):398–405.
  • de Bock GH, Bonnema J, Zwaan RE, et al. Patient’s needs and preferences in routine follow-up after treatment for breast cancer. Br J Cancer. 2004;90(6):1144–1150.